As mentioned above, in colon cancer, SNX10 has been proved to regulate expression of a core effector, P21, in tumor suppressing pathways and to affect metabolism of amino acids mediating activation of mTOR by regulating chaperone-mediated autophagy. The gene discussed is SNX10; the disease is malignant colon neoplasm.